Is this you? Create Your Porfile
Avatar

Macklin Brian Arnold

Eli Lilly and Company

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Macklin Brian Arnold is active.

Explore More

Publication

Featured researches published by Macklin Brian Arnold.

Journal of Medicinal Chemistry | 1998

Synthesis and evaluation of a series of novel 2-[(4-chlorophenoxy)methyl]-benzimidazoles as selective neuropeptide Y Y1 receptor antagonists

Hamideh Zarrinmayeh; Anne Marie Nunes; Paul L. Ornstein; Dennis M. Zimmerman; Macklin Brian Arnold; Douglas A. Schober; Susan L. Gackenheimer; Robert F. Bruns; Philip Arthur Hipskind; Thomas C. Britton; Buddy E. Cantrell; Donald R. Gehlert

Journal of Medicinal Chemistry | 1993

(3SR,4aRS,6RS,8aRS)-6-[2-(1H-tetrazol-5-yl)ethyl]decahydroisoquinoline-3-carboxylic acid : a structurally novel, systemically active, competitive AMPA receptor antagonist

Paul L. Ornstein; Macklin Brian Arnold; Nancy K. Augenstein; David Lodge; Leander Jd; Darryle D. Schoepp

Journal of Medicinal Chemistry | 1998

2-Substituted (2SR)-2-Amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as Potent and Selective Antagonists of Group II Metabotropic Glutamate Receptors. 2. Effects of Aromatic Substitution, Pharmacological Characterization, and Bioavailability

Paul L. Ornstein; Thomas John Bleisch; Macklin Brian Arnold; Jh Kennedy; Rebecca A. Wright; Bryan G. Johnson; Joseph P. Tizzano; Helton; Darryle D. Schoepp; M. Herin

Journal of Medicinal Chemistry | 1991

4-(Tetrazolylalkyl)piperidine-2-carboxylic acids. Potent and selective N-methyl-D-aspartic acid receptor antagonists with a short duration of action.

Paul L. Ornstein; Darryle D. Schoepp; Macklin Brian Arnold; Leander Jd; David Lodge; Jonathan W. Paschal; T. Elzey

Journal of Medicinal Chemistry | 2000

Biarylpropylsulfonamides as novel, potent potentiators of 2-amino-3-(5-methyl-3-hydroxyisoxazol-4-yl)-propanoic acid (AMPA) receptors

Paul L. Ornstein; Dennis M. Zimmerman; Macklin Brian Arnold; Thomas John Bleisch; Buddy E. Cantrell; Richard Lee Simon; Hamideh Zarrinmayeh; Baker; Mary Gates; Joseph P. Tizzano; David Bleakman; Allan Mandelzys; Keith R. Jarvie; Ken Ho; Deverill M; Rajender Kamboj

Journal of Medicinal Chemistry | 1998

2-Substituted (2SR)-2-Amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as Potent and Selective Antagonists of Group II Metabotropic Glutamate Receptors. 1. Effects of Alkyl, Arylalkyl, and Diarylalkyl Substitution

Paul L. Ornstein; Thomas John Bleisch; Macklin Brian Arnold; Rebecca A. Wright; Bryan G. Johnson; Darryle D. Schoepp

Archive | 2007

NOVEL MCH RECEPTOR ANTAGONISTS

Macklin Brian Arnold; Yen Dao; Kevin Matthew Gardinier; David Joseph Garmene; Steven J. Green; Erik James Hembre; Jianliang Lu

Archive | 2009

Inhibitors of diacylglycerol acyltransferase

Macklin Brian Arnold; Thomas James Beauchamp; Emily J. Canada; Erik James Hembre; Jianliang Lu; John Robert Rizzo; John Mehnert Schaus; Qing Shi

Journal of Medicinal Chemistry | 1996

Structure-activity studies of 6-(tetrazolylalkyl)-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 1. Effects of stereochemistry, chain length, and chain substitution

Paul L. Ornstein; Macklin Brian Arnold; Nancy K. Allen; Thomas John Bleisch; Borromeo Ps; Charles Willis Lugar; Leander Jd; David Lodge; Darryle D. Schoepp

Archive | 1999

Amide, carbamate, and urea derivatives

Macklin Brian Arnold; David Michael Bender; Thomas John Bleisch; Winton Dennis Jones; Paul L. Ornstein; Hamideh Zarrinmayeh; Dennis M. Zimmerman

Explore More

Collaboration

Dive into the Macklin Brian Arnold's collaboration.

Top Co-Authors
Avatar

Paul L. Ornstein

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Darryle D. Schoepp

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Dennis M. Zimmerman

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Thomas John Bleisch

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Hamideh Zarrinmayeh

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

David Lodge

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Leander Jd

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Winton Dennis Jones

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

David Michael Bender

Lynn University

View shared research outputs
Top Co-Authors
Avatar

Emily J. Canada

Eli Lilly and Company

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge